FDA clears Victus for corneal incisions

The Victus femtosecond laser platform has received 510(k) clearance from the U.S. Food and Drug Administration for the creation of corneal incisions, according to a press release from Bausch + Lomb. The cuts or incisions can be created in the cornea of patients undergoing cataract surgery or other ophthalmic treatments that require corneal incisions. They can be made in a variety of diameters, depths, angles and planes. The Victus was previously granted FDA clearance for arcuate incisions, for the creation of a corneal flap in patients undergoing LASIK or other (Read more...)

Full Story →